US Stock MarketDetailed Quotes

PFE Pfizer

Watchlist

25.525
+0.395+1.57%

Trading Nov 22 10:11 ET

144.65BMarket Cap34.03P/E (TTM)

Pfizer Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 29, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Oct 1, 2023

(Q2)Jul 2, 2023

(Q1)Apr 2, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

94.13%6.71B

-47.31%-1.78B

-9.91%1.09B

-70.27%8.7B

-38.93%5.24B

-42.07%3.46B

-114.79%-1.21B

-81.49%1.21B

-11.10%29.27B

44.70%8.58B

Net income from continuing operations

287.65%4.48B

-98.68%31M

-43.69%3.13B

-93.08%2.17B

-166.69%-3.34B

-127.63%-2.39B

-76.31%2.34B

-29.50%5.56B

39.81%31.4B

39.77%5B

Depreciation and amortization

12.50%1.76B

10.04%1.73B

16.75%1.74B

24.21%6.29B

9.94%1.67B

31.87%1.56B

33.87%1.57B

25.27%1.49B

-2.45%5.06B

13.78%1.52B

Deferred tax

-326.55%-482M

10.31%-783M

26.25%-441M

8.55%-3.44B

-409.04%-1.86B

-282.26%-113M

23.42%-873M

74.24%-598M

12.32%-3.76B

46.56%-365M

Other non cash items

-46.69%-842M

151.02%274M

-253.00%-353M

-970.00%-4.28B

-127.50%-3.07B

-228.00%-574M

-175.10%-537M

-124.45%-100M

91.48%-400M

-47.27%-1.35B

Change In working capital

173.31%879M

9.73%-3.54B

39.42%-3.34B

61.48%-2.17B

246.03%8.45B

73.85%-1.2B

-41.58%-3.92B

-654.38%-5.51B

-144.04%-5.64B

26.07%2.44B

-Change in receivables

----

32.95%347M

----

106.85%261M

----

-Change in inventory

----

-97.80%-1.17B

----

47.47%-591M

----

-Change in payables and accrued expense

----

-125.19%-300M

----

-4.11%1.19B

----

-Change in other current assets

----

85.29%-663M

----

-326.30%-4.51B

----

-Change in other current liabilities

----

141.06%595M

----

-107.74%-1.45B

----

-Change in other working capital

----

-80.18%-982M

----

53.26%-545M

----

Cash from discontinued investing activities

Operating cash flow

94.27%6.71B

-47.43%-1.78B

-10.07%1.09B

-70.27%8.7B

-38.94%5.24B

-42.15%3.46B

-114.79%-1.21B

-81.47%1.21B

-10.17%29.27B

45.11%8.58B

Investing cash flow

Cash flow from continuing investing activities

-331.24%-2.06B

118.05%4.6B

-47.80%1.73B

-104.50%-32.28B

-149.31%-11B

242.40%890M

-125.26%-25.49B

484.83%3.32B

29.96%-15.78B

-70.84%-4.41B

Net PPE purchase and sale

19.63%-651M

30.31%-637M

38.19%-704M

-20.74%-3.91B

-4.30%-1.04B

3.69%-810M

-21.70%-914M

-77.14%-1.14B

-19.37%-3.24B

0.10%-1B

Net business purchase and sale

--0

--3.49B

-88.85%-43.43B

-158.79%-43.41B

--0

---25M

--0

---23B

---16.77B

Net investment purchase and sale

-204.59%-1.41B

121.88%5.26B

-123.61%-1.06B

128.06%15.24B

150.40%33.44B

137.14%1.35B

-129.11%-24.02B

-39.94%4.47B

134.24%6.68B

911.79%13.35B

Net other investing changes

-98.28%6M

96.37%-19M

105.26%1M

6.25%-180M

66.67%15M

413.51%348M

-580.52%-524M

-46.15%-19M

37.25%-192M

-86.15%9M

Cash from discontinued investing activities

Investing cash flow

-331.64%-2.06B

118.05%4.6B

-47.75%1.73B

-104.51%-32.28B

-149.34%-11B

241.63%888M

-125.27%-25.49B

484.66%3.32B

30.00%-15.78B

-70.53%-4.41B

Financing cash flow

Cash flow from continuing financing activities

-22.68%-4.64B

-109.05%-2.46B

-77.95%-4.93B

275.72%26.07B

208.51%5.44B

34.40%-3.78B

977.95%27.18B

57.88%-2.77B

-51.12%-14.83B

-49.66%-5.02B

Net issuance payments of debt

-57.56%-2.25B

-100.05%-16M

-6,690.63%-2.17B

1,122.33%35.95B

379.98%7.78B

59.44%-1.43B

542.59%29.63B

98.25%-32M

-218.77%-3.52B

-103.74%-2.78B

Net common stock issuance

----

--0

----

---2B

--0

Cash dividends paid

-2.85%-2.38B

-2.81%-2.38B

-3.00%-2.37B

-2.94%-9.25B

-3.12%-2.32B

-3.07%-2.31B

-3.16%-2.32B

-2.40%-2.3B

-2.91%-8.98B

-2.56%-2.25B

Net other financing activities

83.78%-6M

55.32%-63M

11.47%-386M

-88.66%-632M

-357.14%-18M

-840.00%-37M

-192.16%-141M

12.80%-436M

-2,193.75%-335M

-96.52%7M

Cash from discontinued financing activities

Financing cash flow

-22.68%-4.64B

-109.05%-2.46B

-77.95%-4.93B

275.72%26.07B

208.51%5.44B

34.40%-3.78B

978.33%27.17B

57.87%-2.77B

-51.12%-14.83B

-49.66%-5.02B

Net cash flow

Beginning cash position

-58.38%1.12B

-64.90%780M

523.29%2.92B

-76.40%468M

141.63%3.23B

47.92%2.7B

-11.58%2.22B

-76.40%468M

8.66%1.98B

-34.22%1.34B

Current changes in cash

-96.47%20M

-24.95%361M

-220.10%-2.11B

284.37%2.49B

62.68%-315M

236.96%567M

177.21%481M

230.70%1.76B

-722.12%-1.35B

-3,416.67%-844M

Effect of exchange rate changes

128.13%9M

-260.00%-18M

-1,300.00%-28M

75.76%-40M

96.15%-1M

55.56%-32M

92.42%-5M

-100.00%-2M

-179.66%-165M

3.70%-26M

End cash Position

-64.37%1.15B

-58.38%1.12B

-64.90%780M

523.29%2.92B

141.63%3.23B

47.92%2.7B

-11.58%2.22B

-76.40%468M

Free cash flow

129.14%6.06B

-13.95%-2.42B

428.77%386M

-81.59%4.79B

-44.65%4.2B

-48.45%2.65B

-128.60%-2.12B

-98.76%73M

-12.85%26.03B

54.34%7.58B

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 29, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Oct 1, 2023	(Q2)Jul 2, 2023	(Q1)Apr 2, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	94.13%6.71B	-47.31%-1.78B	-9.91%1.09B	-70.27%8.7B	-38.93%5.24B	-42.07%3.46B	-114.79%-1.21B	-81.49%1.21B	-11.10%29.27B	44.70%8.58B
Net income from continuing operations	287.65%4.48B	-98.68%31M	-43.69%3.13B	-93.08%2.17B	-166.69%-3.34B	-127.63%-2.39B	-76.31%2.34B	-29.50%5.56B	39.81%31.4B	39.77%5B
Depreciation and amortization	12.50%1.76B	10.04%1.73B	16.75%1.74B	24.21%6.29B	9.94%1.67B	31.87%1.56B	33.87%1.57B	25.27%1.49B	-2.45%5.06B	13.78%1.52B
Deferred tax	-326.55%-482M	10.31%-783M	26.25%-441M	8.55%-3.44B	-409.04%-1.86B	-282.26%-113M	23.42%-873M	74.24%-598M	12.32%-3.76B	46.56%-365M
Other non cash items	-46.69%-842M	151.02%274M	-253.00%-353M	-970.00%-4.28B	-127.50%-3.07B	-228.00%-574M	-175.10%-537M	-124.45%-100M	91.48%-400M	-47.27%-1.35B
Change In working capital	173.31%879M	9.73%-3.54B	39.42%-3.34B	61.48%-2.17B	246.03%8.45B	73.85%-1.2B	-41.58%-3.92B	-654.38%-5.51B	-144.04%-5.64B	26.07%2.44B
-Change in receivables	----	----	----	32.95%347M	----	----	----	----	106.85%261M	----
-Change in inventory	----	----	----	-97.80%-1.17B	----	----	----	----	47.47%-591M	----
-Change in payables and accrued expense	----	----	----	-125.19%-300M	----	----	----	----	-4.11%1.19B	----
-Change in other current assets	----	----	----	85.29%-663M	----	----	----	----	-326.30%-4.51B	----
-Change in other current liabilities	----	----	----	141.06%595M	----	----	----	----	-107.74%-1.45B	----
-Change in other working capital	----	----	----	-80.18%-982M	----	----	----	----	53.26%-545M	----
Cash from discontinued investing activities				0					0
Operating cash flow	94.27%6.71B	-47.43%-1.78B	-10.07%1.09B	-70.27%8.7B	-38.94%5.24B	-42.15%3.46B	-114.79%-1.21B	-81.47%1.21B	-10.17%29.27B	45.11%8.58B
Investing cash flow
Cash flow from continuing investing activities	-331.24%-2.06B	118.05%4.6B	-47.80%1.73B	-104.50%-32.28B	-149.31%-11B	242.40%890M	-125.26%-25.49B	484.83%3.32B	29.96%-15.78B	-70.84%-4.41B
Net PPE purchase and sale	19.63%-651M	30.31%-637M	38.19%-704M	-20.74%-3.91B	-4.30%-1.04B	3.69%-810M	-21.70%-914M	-77.14%-1.14B	-19.37%-3.24B	0.10%-1B
Net business purchase and sale	--0	--0	--3.49B	-88.85%-43.43B	-158.79%-43.41B	--0	---25M	--0	---23B	---16.77B
Net investment purchase and sale	-204.59%-1.41B	121.88%5.26B	-123.61%-1.06B	128.06%15.24B	150.40%33.44B	137.14%1.35B	-129.11%-24.02B	-39.94%4.47B	134.24%6.68B	911.79%13.35B
Net other investing changes	-98.28%6M	96.37%-19M	105.26%1M	6.25%-180M	66.67%15M	413.51%348M	-580.52%-524M	-46.15%-19M	37.25%-192M	-86.15%9M
Cash from discontinued investing activities
Investing cash flow	-331.64%-2.06B	118.05%4.6B	-47.75%1.73B	-104.51%-32.28B	-149.34%-11B	241.63%888M	-125.27%-25.49B	484.66%3.32B	30.00%-15.78B	-70.53%-4.41B
Financing cash flow
Cash flow from continuing financing activities	-22.68%-4.64B	-109.05%-2.46B	-77.95%-4.93B	275.72%26.07B	208.51%5.44B	34.40%-3.78B	977.95%27.18B	57.88%-2.77B	-51.12%-14.83B	-49.66%-5.02B
Net issuance payments of debt	-57.56%-2.25B	-100.05%-16M	-6,690.63%-2.17B	1,122.33%35.95B	379.98%7.78B	59.44%-1.43B	542.59%29.63B	98.25%-32M	-218.77%-3.52B	-103.74%-2.78B
Net common stock issuance	----	----	----	--0	----	----	----	----	---2B	--0
Cash dividends paid	-2.85%-2.38B	-2.81%-2.38B	-3.00%-2.37B	-2.94%-9.25B	-3.12%-2.32B	-3.07%-2.31B	-3.16%-2.32B	-2.40%-2.3B	-2.91%-8.98B	-2.56%-2.25B
Net other financing activities	83.78%-6M	55.32%-63M	11.47%-386M	-88.66%-632M	-357.14%-18M	-840.00%-37M	-192.16%-141M	12.80%-436M	-2,193.75%-335M	-96.52%7M
Cash from discontinued financing activities
Financing cash flow	-22.68%-4.64B	-109.05%-2.46B	-77.95%-4.93B	275.72%26.07B	208.51%5.44B	34.40%-3.78B	978.33%27.17B	57.87%-2.77B	-51.12%-14.83B	-49.66%-5.02B
Net cash flow
Beginning cash position	-58.38%1.12B	-64.90%780M	523.29%2.92B	-76.40%468M	141.63%3.23B	47.92%2.7B	-11.58%2.22B	-76.40%468M	8.66%1.98B	-34.22%1.34B
Current changes in cash	-96.47%20M	-24.95%361M	-220.10%-2.11B	284.37%2.49B	62.68%-315M	236.96%567M	177.21%481M	230.70%1.76B	-722.12%-1.35B	-3,416.67%-844M
Effect of exchange rate changes	128.13%9M	-260.00%-18M	-1,300.00%-28M	75.76%-40M	96.15%-1M	55.56%-32M	92.42%-5M	-100.00%-2M	-179.66%-165M	3.70%-26M
End cash Position	-64.37%1.15B	-58.38%1.12B	-64.90%780M	523.29%2.92B	523.29%2.92B	141.63%3.23B	47.92%2.7B	-11.58%2.22B	-76.40%468M	-76.40%468M
Free cash flow	129.14%6.06B	-13.95%-2.42B	428.77%386M	-81.59%4.79B	-44.65%4.2B	-48.45%2.65B	-128.60%-2.12B	-98.76%73M	-12.85%26.03B	54.34%7.58B
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data